Journals / Erciyes Tıp Dergisi / 2012 / Cilt: 34 - Sayı: 4

Wilson hastalığı: Beyin manyetik rezonans (MR) görüntüleme ve proton-MR spektroskopi bulguları

Wilson’s disease: Brain MR imaging and proton-MR spectroscopy findings

Pages
197–200
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Spectroscopic findings observed at basal ganglia and both thalami in Wilson’s disease might be due to the neuronal tissue loss and anaerobic glycolysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Wilson’s disease is a rarely seen, autosomal recessive disorder which leads to degenerative changes in the liver and brain due to cupper accumulation in them.
📊
Key Findings & Data:A Wilson syndrome case who was diagnosed 5 years previously with classic symmetric basal ganglia and thalamus involvement in brain MR imaging and increased glutamate-glycine peaks, decreased N-Acetyl Aspartate(NAA)/Creatin(Cre, increased Myoinositol(Mi)/Cre ratios in Multivoxel proton MR spectroscopy with short and long time to echo(TE) values, was presented here.
💡
Conclusion & Impact:Spectroscopic findings observed at basal ganglia and both thalami in Wilson’s disease might be due to the neuronal tissue loss and anaerobic glycolysis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Wilson’s disease is a rarely seen, autosomal recessive disorder which leads to degenerative changes in the liver and brain due to cupper accumulation in them. A Wilson syndrome case who was diagnosed 5 years previously with classic symmetric basal ganglia and thalamus involvement in brain MR imaging and increased glutamate-glycine peaks, decreased N-Acetyl Aspartate(NAA)/Creatin(Cre, increased Myoinositol(Mi)/Cre ratios in Multivoxel proton MR spectroscopy with short and long time to echo(TE) values, was presented here. Spectroscopic findings observed at basal ganglia and both thalami in Wilson’s disease might be due to the neuronal tissue loss and anaerobic glycolysis.

Özet

Wilson hastalığı, bakır metabolizmasındaki bozukluğa bağlı olarak karaciğer ve beyinde bakır birikiminin neden olduğu dejeneratif değisikliklere yol açan, otozomal resesif geçiş gösteren, nadir görülen bir hastalıktır. Beş yıl önce Wilson hastalığı tanısı almış bir olguda, Beyin manyetik rezonans görüntülerinde gözlenen klasik simetrik talamus ve bazal ganglion tutulumu, kısa ve uzun TE değerli Multivoksel proton manyetik rezonans spektroskopide, artmış glutamat ve glisin pikleri, azalmış N-Asetil Aspartat(NAA)/Kreatin(Kre) oranı ve artmış Myoinositol(Mi)/Kre oranı saptandı. Wilson hastalığında bazal gangliyonlarda ve talamuslarda saptanan spektroskopik bulguların yaygın nöral doku kaybı ve anaerobik glikolize bağlı olduğu düşünülmüştür.

🔖

Cite This Article

KIZILGÖZ, V., DAMAR, Ç., HEKİMOĞLU, B., AYDIN, H. (2022). Wilson hastalığı: Beyin manyetik rezonans (MR) görüntüleme ve proton-MR spektroskopi bulguları. Erciyes Tıp Dergisi, Cilt: 34 - Sayı: 4, 197–200. https://ajindex.com/articles/502444

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Aluçlu MU. İlk bulgusu Ekstrapiramidal semptom olan Wilson hastalığı. Dicle Tıp Dergisi 2007; 34(2): 127-30
  2. Savranlar A, Ozer T, Aydemir S, Alkan A, Borazan A. Proton magnetic Resonance Spectroscopy Findings of Wilsons disease. J of Neurological sciences 2005; 22(3): 297-303
  3. Jayasundar R, Sahani AK, Gaikwad S, Singh S, Behari M. Proton MR spectroscopy of bazal ganglia in Wilsons disease. Magnetic Resonance Imaging 2002; 20(1): 131-5. [CrossRef] 4. Lucato L, Otaduy MC, Barbosa ER, Machado AC, McKinney A. Proton MR Spectroscopy in Wilson disease. Analysis of 36 Cases. AJNR 2005; 26(5): 1066-71
  4. Alanen A, Komu M, Penttinen M, Leino R. Magnetic resonance imaging and proton MR Spectroscopy in Wilsons disease. British J of Radiology 1999; 72(860): 749-56
  5. Kalra V, Mhajan S, Kesarwani PK. Rare presentation of Wilsons disease, a case report. Int Urol Nephrol 2004; 36(2): 289-91. [CrossRef] 7. Sener RN. Diffusion MRI findings in Wilsons disease. Comput Med Imaging Graph 2003; 27(1): 17-21. [CrossRef] 8. Das SK, Ray K. Wilsons Disease: An update, Nature Clinical Practice in Neurology 2006; 2(9): 482-93. [CrossRef] 9. Kraft E, Trenkwalder C, Bergh FT, Auer DP. Magnetic resonance proton MR spectroscopy of the brain in Wilson’s disease. J Neurol 1999; 246(8): 693-9. [CrossRef] 10. Van Den Heuvel AG, Van Der Grond J, Van Roooij, Van Wassenaer HN, Hoogenraad TU, Mali WP. Differentation between porto-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR Spectroscopy. Radiology 1997; 203(2): 539-43.